UroGen Pharma(URGN) - 2024 Q3 - Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q3 2024 Earnings Call Transcript November 6, 2024 10:00 AM ET Company Participants Vincent Perrone - Head of IR Liz Barrett - President and CEO Mark Schoenberg - CMO David Lin - CCO Chris Degnan - CFO Conference Call Participants Tara Bancroft - TD Cowen Ram Selvaraju - H. C. Wainwright & Co. Leland Gershel - Oppenheimer Kelsey Goodwin - Guggenheim Matt Kaplan - Ladenburg Thalmann Operator Good morning, ladies and gentlemen. Thank you for standing by and welcome to the UroGe ...